Quick Answer
Anika Therapeutics, Inc. reported Shares Outstanding of 13.89 million shares for fiscal year 2025.
Anika Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 13.89M | -3.7% |
| 2024 | 14.42M | -1.7% |
| 2023 | 14.66M | +0.2% |
| 2022 | 14.62M | +1.3% |
| 2021 | 14.44M | +0.8% |
| 2020 | 14.33M | +0.1% |
| 2019 | 14.31M | +0.7% |
| 2018 | 14.21M | -3.3% |
| 2017 | 14.69M | +0.4% |
| 2016 | 14.63M | -2.7% |
| 2015 | 15.04M | +1.2% |
| 2014 | 14.85M | +3.9% |
| 2013 | 14.29M | +3.1% |
| 2012 | 13.87M | +1.7% |
| 2011 | 13.63M | +1.1% |
| 2010 | 13.48M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 14.42M | -1.9% | +0.0% |
| June 30, 2025 | 14.42M | -2.8% | +0.6% |
| March 31, 2025 | 14.34M | -3.3% | -0.6% |
| December 31, 2024 | 14.42M | -1.7% | -1.9% |
| September 30, 2024 | 14.69M | +0.4% | -1.0% |
| June 30, 2024 | 14.84M | +1.2% | +0.1% |
| March 31, 2024 | 14.82M | +0.5% | +1.1% |
| December 31, 2023 | 14.66M | +0.2% | +0.2% |
- Anika Therapeutics, Inc. showed a decrease of -3.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Anika Therapeutics, Inc.’s shares outstanding has grown by 3.0% (from 13.48 million shares to 13.89 million shares).
- The most recent figure is from Anika Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: